Theranos Investor Conference Presentation Deck

Presentation Overview 1. Miniaturization of laboratory testing II. miniLab results across detection methodologies III. Small sample volumes: collection of capillary blood and analysis This technology has not been cleared or approved by the FDA and is not for sale in the United States. theranos 58

View entire presentation